Table 4.

Presentation and outcomes of patients with metastatic infection

Patient No.Graft LocationAge/GenderPresenting SymptomsOrganismHow dx MadeMetastic InfectionDays in HospitalProceduresPatient Outcome
1TH35/FFever, AMS, toe necrosisMRSAClinPeripheral septic emboli16Survived
2TH37/FFever, SOBVRETEEEndocarditis (AV and MV)12AVR, MV repairSurvived
3TH45/FFever, SOB, hypoxemiaMRSAChest CTSeptic pulmonary emboli8Survived
4TH39/MFever, rigorsMSSATTEEndocarditis (MV)6MVR, remove RA vegetationDied at 16 days
5TH45/FFever, SOBVRETEEEndocarditis (AV)13Died at 58 days
6TH58/MSOB, weaknessMRSA, EnterobacterChest CTSeptic pulmonary emboli16Survived
7UE58/MFever, SOB, CHBMRSATTEEndocarditis (MV)15MVRSurvived
8UE71/MFever, AMSMSSABrain MRISeptic emboli22Died at 22 days
9UE50/MFever, SOB, a fibMRSA, VRETTEEndocarditis (MV)26Survived
  • TH, thigh; UE, upper extremity; SOB, shortness of breath; AMS, altered mental status; CHB, complete heart block; a fib, atrial fibrillation; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus; TTE, transthoracic echocardiogram; TEE, transesophageal echocardiogram; CT, computed tomography; MRI, magnetic resonance imaging; MV, mitral valve; AV, aortic valve; MVR, mitral valve replacement; AVR, aortic valve replacement; RA, right atrium; dx, diagnosis; Clin, clinically.